surmount-1 tirzepatide non-diabetic obesity trial Clinical trials of subcutaneous (SURMOUNT-1, -2 and -3 Comparative Efficacy and Safety of

Understanding these hormonal shifts can be the first step toward effective treatment during this transition

The most robust clinical evidence to date concerns the improvement of muscular and metabolic parameters (strength, endurance, insulin sensitivity) and the modulation of chronic inflammation. A 2024 randomised trial comparing NAD IV with NR IV in healthy adults showed that both modalities increase the available NAD pool, with a favourable safety profile

They can make people feel less confident, and some even observe depression or anxiety due to their impact on facial expression

Emerging reports suggest that GLP-1 medications, such as Ozempic and Wegovy, may impair fertility in both men and women, raising potential implications for future product liability claims

This approach would help in a more balanced way

I want to live at least 20 more years for my kids. On how she did it: I eat what I like to eat